Patents Act 1970 Safeguarding Innovation in India

Innovation powers growth, but without legal protection, inventions can easily be copied or misused. The Patents Act, 1970 gives inventors in India the ability to protect their creativity, secure commercial benefits, and share knowledge for public good. By granting a 20-year monopoly right, this Act ensures that inventors can stop others from making, using, selling, or importing their invention without consent.

For Indian innovators, entrepreneurs, and businesses, understanding the patents act is not just about legal compliance it is about turning ideas into valuable assets.

What the Patents Act 1970 Requires

Under Section 2(1)(j) of the Patents Act, 1970, an invention must meet three essential conditions:

• Novelty: The invention must be new and not disclosed anywhere before the filing date.
• Inventive Step: It should not be obvious to someone skilled in that field.
• Industrial Application: It must be capable of use in an industry.

The Patent Act 2005 made major amendments, introducing product patents across all sectors, especially pharmaceuticals, aligning India with global TRIPS obligations.

Crucial Exceptions to Patentability (Section 3)

Not all ideas qualify for protection. The Patents Act, 1970 specifically excludes certain categories:

• Section 3(d): Prevents evergreening companies cannot secure patents for minor modifications of known substances unless they significantly improve efficacy.
• Section 3(k): Excludes algorithms and abstract software unless they produce a genuine technical effect.
• Defense-Related Inventions: Certain technologies may remain secret, similar in principle to the U.S. Invention Secrecy Act of 1951, though India has its own secrecy provisions.

These safeguards balance private rights with public interest.

Compulsory Licensing: Balancing Rights and Public Health

Sections 84 and 92 introduce Compulsory Licensing (CL), which allows third parties to manufacture a patented invention without the owner’s consent in cases such as:

• The invention is not available at an affordable price.
• The public’s requirement is unmet.
• The invention is not worked in India.

This mechanism ensures accessibility to life-saving drugs and essential technologies.

Case Law Update – Bayer v. Natco Pharma (2025): The Delhi High Court reaffirmed compulsory licensing principles, granting Natco Pharma a license to produce Bayer’s patented cancer drug at affordable prices. The Court emphasised that public health outweighs commercial monopoly.

Landmark Judicial Developments

• Novartis AG v. Union of India (2013, upheld in 2025): The Supreme Court denied a patent for a modified cancer drug, reinforcing Section 3(d) and India’s stance against evergreening.
• Software Patent Cases: High Courts now examine whether software inventions produce real-world technical effects or remain abstract algorithms.

Together, these judgments highlight how courts maintain a balance between rewarding inventors and ensuring social welfare.

Insights: Why Issues Arise and What to Do

• Why Challenges Exist

1. Global companies often push to extend patent monopolies.
2. Many Indian startups lack awareness of patent eligibility.
3. High costs and lengthy procedures discourage inventors.

• Steps Inventors Should Take

1. File a provisional patent early to secure priority.
2. Conduct prior art searches to ensure novelty.
3. Work with IP lawyers for drafting and compliance.
4. File oppositions under Section 25 if patents are wrongly granted.

• How Individuals Can Respond

1. If you believe a patent is misused or overpriced, you can initiate a pre-grant or post-grant opposition.
2. Collaborate with legal experts to safeguard your work and challenge unfair practices.

Outlook: The Future of the Patents Act in India

India’s patent regime is evolving to keep pace with AI, biotech, renewable energy, and software-based inventions. Future reforms may include:

• Faster digital filing and examination systems.
• Clearer rules for AI-driven and software innovations.
• Stronger enforcement against patent infringement.

This evolution will strengthen India’s position as a global innovation hub while ensuring affordable access to critical technologies.

Conclusion

The Patents Act, 1970 is more than a legal document it is a framework that protects inventors while safeguarding public interest. By learning the key provisions, including the Patent Act 2005 amendments and compulsory licensing rules, innovators can secure their rights and contribute to India’s progress.

Every inventor deserves recognition, protection, and a fair chance to benefit from their ingenuity.

Disclaimer

This article is for informational purposes only and does not constitute legal advice. Please consult a qualified legal professional for specific guidance.

About Tigde Law Firm

Tigde Law Firm is recognised among the top 10 law firms in India, offering full-service legal expertise in complex areas including EOW, ED, corporate law, property, builder disputes, divorce, civil, commercial, and criminal cases. Headquartered in Thane with offices across Mumbai and Navi Mumbai, Tigde Law Firm serves clients nationwide with a strong team of over 100 lawyers. From local courts to the High Court and Supreme Court, TLF leads with trusted, result-driven advocacy.

Founded by Sachin Subhash Tigde and Shubhash Tigde, both experienced High Court lawyers in Maharashtra with a legacy of over 45 years and second-generation expertise, the firm has handled more than 5,000 cases. With 50+ in-house advocates across Mumbai, Navi Mumbai, and Thane, Tigde Law Firm is widely regarded as the best law firm in Thane and home to some of the most reliable advocates and lawyers in Thane. Specialising in property and redevelopment matters, RERA compliance, society disputes, divorce, NCLT, civil, criminal, corporate, and IP law, TLF delivers clarity and confidence to clients facing complex legal challenges.

Call Now for professional legal assistance legal matters:

• Phone: +91 9326261981
• Email: inquiry@tigdelawfirm.com